Rare diseases
Investigational molecules
Locations
Back to France478 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease
FranceStudy on Impulsivity Control in Adults with Tourette Syndrome Using [18F]-Altanserin and Aripiprazole
FranceStudy of Anifrolumab for Children and Teens with Moderate to Severe Lupus
FranceStudy on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery
FranceStudy on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse
FranceStudy on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer
FranceStudy Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer
FranceStudy on Tezepelumab for Children Aged 5 to 11 with Severe Asthma
FranceStudy on Protamine Sulfate to Reduce Neurological Events After Aortic Valve Implantation in Patients with Aortic Stenosis
FranceStudy on the Safety and Effects of Radiprodil for Children with GRIN-related Disorder
FranceStudy on Alpelisib for Treating Lymphatic Malformations in Patients with PIK3CA Mutation
FranceStudy on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.
Studies include neuroinflammation assessment and serotonergic receptor expression analysis.
Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.
Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.
Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.
Emphasis on developing effective treatments for previously undertreated rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
